On June 25, 2026, the clinical trial registry listed an update for a study involving insulin detemir. The trial, titled "DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes," is registered under identifier NCT06445946. This is a Phase 4 trial. Its current status is recruiting, meaning the study is actively enrolling participants as of the listed date. The trial is designed to compare treatment approaches for gestational diabetes, evaluating metformin against insulin based treatments. No results have been posted for this trial at this time. The registry entry does not provide outcome data, efficacy claims, or safety findings. Interested parties can review the full trial record through the official registry listing for further details on eligibility, design, and objectives. For more background on insulin detemir, readers can consult the compound overview.</body_markdown>
<parameter name="sources">["https://clinicaltrials.gov/study/NCT06445946"]